Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FX2EZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,736
Award facts
- Contract value 100% obligated
- $51,736.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,736.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120 count units). This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of DMS Pharmaceutical Group's established role as a key supplier within the federal pharmaceutical supply chain. The award carries no set-aside designation, demonstrating the vendor's competitive standing in open federal procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 through November 2026. This overarching contract enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables for Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment, aligns with the IDC's extensive portfolio spanning multiple therapeutic categories and delivery formats, positioning DMS Pharmaceutical Group as a critical distributor supporting military health facility pharmaceutical needs across the globe.
Quick answers
Who was awarded contract SPE2DB25FX2EZ?
SPE2DB25FX2EZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FX2EZ worth?
The government has obligated $51,736 on SPE2DB25FX2EZ.
Is contract SPE2DB25FX2EZ an order under another contract?
Yes. SPE2DB25FX2EZ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2EZ competed?
The extent of competition for SPE2DB25FX2EZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award